Arsenic mediates cell proliferation and gene expression in the bladder epithelium association with activating protein-1 transactivation

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3445-3453

  Simeonova, Petia P ^a   Wang, Shiyi ^a   Toriuma, Wataru ^a,b   Kommineni, Vera ^a   Matheson, Joanna ^a   Unimye, Nyseo ^c   Kayama, Fujio ^d   Harki, Dan ^a   Ding, Min ^a   Vallyathan, Val ^a   Luster, Michael I ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Tako Chuo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; DNA; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; BLADDER EPITHELIUM; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; REPORTER GENE; TRANSACTIVATION; TRANSITIONAL CELL CARCINOMA;

ANIMALS; ARSENATES; ARSENITES; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIVISION; CROSSES, GENETIC; DNA DAMAGE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; HUMANS; HYPERPLASIA; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; PROTEINS; SODIUM COMPOUNDS; TETRADECANOYLPHORBOL ACETATE; TISSUE DISTRIBUTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; URINARY BLADDER; UROTHELIUM;

EID: 0034235541     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Chiang, H. S., Guo, H. R., Hong, C. L., Lin, S. M., and Lee, E. F. The incidence of bladder cancer in the blackfoot disease endemic area in Taiwan. Br. J. Urology, 71: 274-278, 1993.
2. Chiou, H. Y., Hsueh, Y. M., Liaw, K. F., Horng, S. F., Chiang, M. H., Pu, Y. S., Lin, J. S. N., Huang, C. H., and Chen, C. J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res., 55: 1296-1300, 1995.
3. Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicoli, H., and Smith, A. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology, 7: 117-124, 1996.
4. Smith, A., Goycolea, M., Haque, R., and Biggs, M. L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol., 147: 660-669, 1998.
5. Tsuda, T., Babazono, A., Yamamoto, E., Kurumatini, N., Mino, Y., Ogawa, T., Kishi, Y., and Aoyama, H. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am. J. Epidemiol., 141: 198-209, 1995.
6. Smith, A. H., Hopenhayn-Rich, C., Bates, M. N., Goeden, H. M., Hertz-Picciotto, I., Duggan, H. M., Wood, R., Kosnett, M. J., and Smith, M. T. Cancer risks from arsenic in drinking water. Environ. Health Perspect., 97: 259-267, 1992.
7. Karagas, M. R., Tosteson, T. D., Blum, J., Morris, J. S., Baron, J. A., and Klaue, B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U. S. population. Environ. Health Perspect., 106: 1047-1050, 1998.
8. Lewis, D. R., Southwick, J. H. W., Ouellet-Hellstrom, R., Rench, J., and Calderon, R. L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect., 107: 359-365, 1999.
9. Jacobson-Kram, D., and Montalbano, D. The reproductive effects assessment group's report on mutagenicity of inorganic arsenic. Environ. Mutagen, 7: 787-804, 1985.
10. Liu, Y., Guyton, K. Z., Gorospe, M., Xu, Q., Lee, J. C., and Holbrook, N. J. Differential activation of ERK, JNK/SAPK and P38/CSBP/RK map kinase family members during the cellular response to arsenite. Free Radical Biol. Med., 21: 771-781, 1996.
11. Cavigelli, M., Li, W. W., Lin, A., Su, B., Yoshioka, K., and Karin, M. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J., 15: 6269-6279, 1996.
12. Chen, W., Martindale, J. L., Holbrook, N. J., and Liu, Y. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and shc. Mol. Cell Biol., 18: 5178-5188, 1998.
13. Huang, C., Ma, W. Y., Li, J., Goranson, A., and Dong, Z. Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J. Biol. Chem., 274: 14595-14601, 1999.
14. Germolec, D. R., Spalding, J., Yu, H-S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., and Luster, M. I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol., 153: 1775-1785, 1998.
15. Klimecki, W. T., Borchers, A. H., Egbert, R. E., Nagle, R. B., Carter, D. E., and Bowden, G. T. Effects of acute and chronic arsenic exposure of human-derived kertinocytes in an in vitro human skin equivalent system: a novel model of human arsenicism. Toxicol. In Vitro, 11: 89-98, 1997.
16. Brown, J. L., and Kitchin, K. T. Arsenite, but not cadmium, induces ornithine decarboxylase and heme oxygenase activity in rat liver: relevance to arsenic carcinogenesis. Cancer Lett., 98: 227-231, 1996.
17. Burleson, F. G., Simeonova, P. P., Germolec, D. R., and Luster, M. I. Dermatotoxic chemical stimulation of c-jun and c-fos transcription and AP-1 DNA binding in human keratinocytes. Res. Commun. Mol. Pathol. Pharmacol., 93: 131-148, 1996.
18. Huang, C., Ma, W. Y., Dawson, M. I., Rincon, M., Flavell, R. A., and Dong, Z. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc. Natl. Acad. Sci. USA, 94: 5829-5830, 1997.
19. Crecelius, E. A. Chemical speciation of arsenic in water and tissue by hydride generation quartz furnace atomic absorption spectrometry. Method 1632, U. S. Environ. Prot. Agency, Washington, DC, 1998.
20. Petzoldt, L., Leigh, I. M., Duffy, P. G., Sexton, C., and Masters, R. W. Immortalisation of human urothelial cells. Urol. Res., 23: 377-380, 1995.
21. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res., 17: 6420-6427, 1989.
22. Simeonova, P. P., Toriumi, W., Kommineni, C., Erkan, M., Munson, A., Rom, W., and Luster, M. I. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells. J. Immunol., 159: 3921-3928, 1997.
23. Rice, J. M., Baan, R. A., Blettner, M., Genevios-Charmeau, C., Grosse, Y., McGregor, D. B., Partensky, C., and Wilbourn, J. D. Rodent tumors of urinary bladder, renal cortex, and thyroid gland in IARC Monographs Evaluations of Carcinogenic risk to humans. Toxicol. Sci., 49: 166-171, 1997.
24. Zhang, X., and Takenaka, I. Morphological changes of microvilli on different surfaces of epithelial cells in the rat bladder treated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol. Res., 23: 371-376, 1995.
25. Vahter, M. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res., 25: 286-293, 1981.
26. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta., 1072: 129-157, 1991.
27. Tiniakos, D. G., Mellon, K., Anderson, J. J., Robinson, M. C., Neal, D. E., and Horne, C. H. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder. Br. J. Urol., 74: 757-761, 1994.
28. Skopelitou, A., Hadjiyannakis, M., Dimopoulos, D., Kamina, S., Krikoni, O., Alexopoulou, V., Rigas, C., and Agnantis, N. J. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage. Eur. Urol., 31: 464-471, 1997.
29. Outinen, P. A., Sood, S. K., Pfeifer, S. I., Pamidi, S., Podor, T. J., Li, J., Weitz, J. I., and Austin, R. C. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood, 94: 959-967, 1999.
30. Cabibbo, A., Consalez, G. G., Sardella, M., Sitia, R., and Rubartelli, A. Changes in gene expression during the growth arrest of HepG2 hepatoma cells induced by reducing agents or TGFβ1. Oncogene, 16: 2935-2944, 1998.
31. Kanisawa, M., and Schroder, H. A. Life term studies on the effect of trace elements on spontaneous tumors in mice and rats. Cancer Res., 29: 892-895, 1969.
32. Hamilton, J. W., Kaltreider, R. C., Bajenova, O. V., Ihnat, M. A., McCaffrey, J., Turpie, B. W., Rowell, E. E., Oh, J., Nemeth, M. J., Pesce, C. A., and Lariviere, J. P. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ. Health Perspect., 106: 1005-1015, 1998.
33. United States Environmental Protection Agency. Special Report on Ingested Inorganic Arsenic: Skin Cancer and Nutritional Essentiality. Risk Assessment Forum. Washington, DC: United States Environmental Protection Agency, 1987.
34. Yamamoto, S., Konishi, Y., Matsuda, T., Murial, T., Shibata, M-A., Matsui-Yuasa, I., Otani, S., Kuroda, K., Endo, G., and Fukushima, S. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res., 55: 1271-1276, 1995.
35. Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., and Fukushima, S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis (Lond.), 20: 1873-1876, 1999.
36. Arnold, L. L. Cano, M., St. John, M., Eldan, M., van Gemert, M., and Cohen, S. M. Effects of dietary dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis (Lond.), 20: 2171-2179.
37. Snow, E. T. Metal carcinogenesis: Mechanistic implications. Pharmacol. Ther., 53: 31-65, 1992.
38. Shimizu, M., Hochadel, J. F., Fulmer, B. A., and Waalkes, M. P. Effect of glutathione depletion and metallothionein gene expression on arsenic-induced cytotoxicity and c-myc expression in vitro. Toxicol. Sci., 45: 204-211, 1998.
39. Guyton, K. Z., Xu, Q., and Holbrook, N. J. Induction of the mammalian stress response gene GADD153 by oxidative stress: role of AP-1 element. Biochem. J., 314: 547-554, 1996.
40. Germolec, D. R., Yoshida, T., Gaido, K., Wilmer, J. L., Simeonova, P. P., Kayama, F., Burleson, F., Dong, W., Lange, R. W., and Luster, M. I. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol., 141: 308-318, 1996.
41. Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M. G., and Packer, L. Redox regulation of NF-κB activation. Free Radical Biol. Med., 22: 1115-1126, 1997.
42. Chow, N. H., Guo, Y. L., Lin, J. S. N., Su, J. H. J., Tzai, T. S., Guo, H. R., and Su, I. J. Clinicopathological features of bladder cancer associated with chronic exposure to arsenic. Br. J. Cancer, 75: 1708-1710, 1997.
43. Hofer, G., Grimmer, C., Sukhatme, V. P., Sterzel, R. B., and Rupprecht, H. D. Transcription factor EGR-1 regulates glomerular mesangial cell proliferation. J. Biol. Chem., 271: 28306-28310, 1996.
44. Eid, M. A., Kumar, V., Iczkowski, K. A., Bostwick, D. G., and Tindall, D. J. Expression of early growth response genes in human prostate cancer. Cancer Res., 58: 2461-2468, 1998.